Home
About
FAQ
History (5)
A randomized, placebo-controlled phase 2 study of ganitumab (AMG 479) or conatumumab (AMG 655) in combination with gemcitabine in patients with metastatic pancreatic cancer.
Brief Commentary: Marijuana and Cardiovascular Disease-What Should We Tell Patients?
Effect of visceral metastases on the efficacy and safety of everolimus in postmenopausal women with advanced breast cancer: subgroup analysis from the BOLERO-2 study.
PCSK9: From Basic Science Discoveries to Clinical Trials.
The Intersection of Diabetes and Cardiovascular Disease-A Focus on New Therapies.
See All 5 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
PCSK9: From Basic Science Discoveries to Clinical Trials.
Shapiro MD, Tavori H, Fazio S. PCSK9: From Basic Science Discoveries to Clinical Trials. Circ Res. 2018 05 11; 122(10):1420-1438.
View in:
PubMed
subject areas
Animals
Antibodies, Monoclonal
Atherosclerosis
Cardiovascular Diseases
Cholesterol
Dyslipidemias
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Lipoproteins
Liver
Mice
Protein Processing, Post-Translational
Randomized Controlled Trials as Topic
Receptors, LDL
Risk Factors
RNA Interference
Treatment Outcome
Vaccination
authors with profiles
Michael D. Shapiro DO, MCR